{
    "doi": "https://doi.org/10.1182/blood.V126.23.2811.2811",
    "article_title": "Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors? ",
    "article_date": "December 3, 2015",
    "session_type": "634. Myeloproliferative Syndromes: Clinical: Poster II",
    "abstract_text": "Thrombotic events are major complications in patients (pts) affected by Essential Thrombocytemia (ET) and Polycytemia Vera (PV). To compare thrombotic risk in these 2 groups, we evaluated retrospectively our database of 1249 ET and 623 PV pts diagnosed and followed in 11 hematological centers in the Latium region between 1/1980 and 12/2010: the diagnosis was done according to PVSG, WHO 2001 and 2008criteria based on the time of first observation. Baseline features of ET pts: 797F/452M,median age 62.9 yrs (range 19-96),median WBC count 8.8 x 10 9 /L (range 1.2-57.7), median PLT count 812 x 10 9 /L (range 457-3582), median Hb level 14.0 g/dl (range 6-20.5), JAK-2 V617F positivity 59.7% with a median allele burden of 19,6% (range 0.2- 99.9), spleen enlargement in 18.7% of pts, previous thrombosis223/1239 evaluable pts (17.9%) [arterial 176/223 (14.1%), venous 47/223 (3.8%)]. Baseline features of PV pts: 289F/334M, median age 63.0yrs (range 21-91), median WBC count 10.1 x 10 9 /L (range 3.5-37.6), median PLT count 457 x 10 9 /L (range 169-1790), median Hb level 18.2 g/dl (range 10.5-24.8), JAK-2 V617F positivity 94.3% with a median allele burden of 59.1% (range 0.3-99.9), spleen enlargement in 42% of patients, previous thrombosis 146/617 evaluable pts (23.7%)[arterial 114/617 (18.5%), venous 32/617 (5,2%)].in the ET cohort, after a median follow-up of 7.7 yrs, thrombotic complications were seen in 107/1141 evaluable pts (9.4%) [arterial60 (5.25%), venous 47 (4.11%)]; in the PV cohort, after a median follow-up of 8.5 yrs, thrombotic complications were seen in 107/623pts (17.2%) [arterial 67 (10.8%),venous 40 (6.4%)].All common risk factors for thrombosis were evaluated in multivariate analysis, searching the cut-off number for continuous variables with ROC curves. The significant variables at multivariate analysis for ET and PV pts are shown in the table; age, previous thromboses and spleen enlargement were risk factors in ET pts, while previous thromboses and JAK-2 V617F allele burden were risk factors in PV pts. PLT count above ROC value seemed to be a protective factor in both cohorts. In conclusion, in contrast with the tendency to evaluate in a similar manner the thrombotic risk of PV and ET, data from our retrospective database showed that these 2 groups should be considered populations with different risk factors for thrombosis. Table 1.  Putative prognostic factors . . Polycythemia Vera . Essential Thrombocythemia . . HR . 95% C.I. . p . HR . 95% C.I . . p . Previous thromboses  2,31  1,13 - 4,74  0,02  1,87  1,08 -3,23  0,026  Age \u2265 60 y  1,54 0,79 - 2,99 0,21 1,90  1,18 - 3,06  0,009  JAK2 V617F  PV: allelic burden \u2265 81% ET: pos 1,95  1,03 - 3,71  0,04  0,76 0,48 - 1,21 0,25 Plt count  PV \u2265 452.10 9 /L ET \u2265 944.10 9 /L 0,49  0,25 - 0,95  0,04  0,52  0,31 - 0,89  0,017  Spleen enlargement  0,67 0,34 -1,31 0,24 1,71  1,02 - 2,89  0,04  CV risk factors (at least 1)  0,92 0,41 - 2,03 0,83 0,87 0,51 - 1,49 0,62 WBC  PV \u2265 10,175.10 9 /L ET \u2265 9,630.10 9 /L 1,09 0,57 - 2,08 0,80 1,41 0,89 -2,26 0,15 Putative prognostic factors . . Polycythemia Vera . Essential Thrombocythemia . . HR . 95% C.I. . p . HR . 95% C.I . . p . Previous thromboses  2,31  1,13 - 4,74  0,02  1,87  1,08 -3,23  0,026  Age \u2265 60 y  1,54 0,79 - 2,99 0,21 1,90  1,18 - 3,06  0,009  JAK2 V617F  PV: allelic burden \u2265 81% ET: pos 1,95  1,03 - 3,71  0,04  0,76 0,48 - 1,21 0,25 Plt count  PV \u2265 452.10 9 /L ET \u2265 944.10 9 /L 0,49  0,25 - 0,95  0,04  0,52  0,31 - 0,89  0,017  Spleen enlargement  0,67 0,34 -1,31 0,24 1,71  1,02 - 2,89  0,04  CV risk factors (at least 1)  0,92 0,41 - 2,03 0,83 0,87 0,51 - 1,49 0,62 WBC  PV \u2265 10,175.10 9 /L ET \u2265 9,630.10 9 /L 1,09 0,57 - 2,08 0,80 1,41 0,89 -2,26 0,15 View Large Disclosures No relevant conflicts of interest to declare.",
    "topics": [
        "thrombus",
        "brachial plexus neuritis",
        "thrombosis",
        "splenomegaly",
        "follow-up",
        "thrombocythemia, hemorrhagic",
        "polycythemia vera",
        "prognostic factors",
        "leukocyte count",
        "heart disease risk factors"
    ],
    "author_names": [
        "Alessandro Andriani, MD",
        "Roberto Latagliata, MD",
        "Michele Cedrone, MD",
        "Ambra Di Veroli, MD",
        "Cristina Santoro, MD",
        "Francesca Spirito",
        "Carla Ruscio",
        "Sabrina Crescenzi-Leonetti",
        "Raffaele Porrini, MD",
        "Jonny Di Giandomenico",
        "Nicoletta Villiv\u00e0",
        "Antonio Spadea, MD",
        "Angela Rago, MD",
        "Cinzia De Gregoris",
        "Paolo Cercola",
        "Barbara Anaclerico, MD",
        "Marianna De Muro, MD",
        "Stefano Felici, MD",
        "Massimo Breccia, MD",
        "Enrico Montefusco, MD",
        "Antonino Bagnato, MD",
        "Giuseppe Cimino, MD",
        "Ignazio Majolino, MD",
        "Maria Gabriella Mazzucconi, MD",
        "Giuliana Alimena, MD",
        "Marco Montanaro, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Alessandro Andriani, MD",
            "author_affiliations": [
                "UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Roberto Latagliata, MD",
            "author_affiliations": [
                "Department of Hematology, University, Rome, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Cedrone, MD",
            "author_affiliations": [
                "UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ambra Di Veroli, MD",
            "author_affiliations": [
                "Hematology, Tor Vergata University, Rome, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cristina Santoro, MD",
            "author_affiliations": [
                "University of Rome \"Sapienza\", Department of Cellular Biotechnologies and Hematology, Rome, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Spirito",
            "author_affiliations": [
                "UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carla Ruscio",
            "author_affiliations": [
                "UOC of Hematology and bone marrow transplantation, San Camillo-Forlanini Hospital, Rome, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sabrina Crescenzi-Leonetti",
            "author_affiliations": [
                "UOC of Hemtology, San Giovanni Hospital, Rome, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raffaele Porrini, MD",
            "author_affiliations": [
                "Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jonny Di Giandomenico",
            "author_affiliations": [
                "UOC of Hematology and bone marrow transplantation, University of PTV, Rome, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicoletta Villiv\u00e0",
            "author_affiliations": [
                "UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Spadea, MD",
            "author_affiliations": [
                "Clinical Oncology, Istituto Regina Elena, Rome, Italy "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angela Rago, MD",
            "author_affiliations": [
                "UOC of Hematology, University, Latina, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cinzia De Gregoris",
            "author_affiliations": [
                "UOC of Hematology, ASL VT, Viterbo, Italy "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Cercola",
            "author_affiliations": [
                "ASL VT, Molecolar Laboratory, Viterbo, Italy "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Barbara Anaclerico, MD",
            "author_affiliations": [
                "Hematology, San Giovanni - Addolorata Hospital, Rome, Italy "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marianna De Muro, MD",
            "author_affiliations": [
                "Hematology, Univ. Campus Bio Medieo, Rome, Italy"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Felici, MD",
            "author_affiliations": [
                "UOSA of Hematology, ASL RMA, Nuovo Regina Margherita Hospital, Rome, Italy "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Breccia, MD",
            "author_affiliations": [
                ". Department of Hematology, University of Rome \"La Sapienza\", Rome, Italy "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Enrico Montefusco, MD",
            "author_affiliations": [
                "Hematology Unity, Sant'Andrea Hospital, Rome, Italy "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonino Bagnato, MD",
            "author_affiliations": [
                "UOC of Hematology, San Giovanni Hospital, Rome, Italy "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Cimino, MD",
            "author_affiliations": [
                "S.M. Goretti, UOC Hematology, Latina, Italy "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ignazio Majolino, MD",
            "author_affiliations": [
                "Department of Hematology, Ospedale S. Camillo, Rome, Italy "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Gabriella Mazzucconi, MD",
            "author_affiliations": [
                "Centro Regionale di Riferimento per l'Emofilia e Sindromi Correlate, Universit\u00e0 Sapienza, Policlinico Umberto I, Rome, Italy "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuliana Alimena, MD",
            "author_affiliations": [
                "Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marco Montanaro, MD",
            "author_affiliations": [
                "ASL VT, UOC of Hemathology, Viterbo, Italy"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-04T06:43:22",
    "is_scraped": "1"
}